Print Page  |  Close Window

SEC Filings

8-K
TEVA PHARMACEUTICAL INDUSTRIES LTD filed this Form 8-K on 02/08/2018
Entire Document
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TEVA PHARMACEUTICAL INDUSTRIES LTD.

 

Date: February 8, 2018 By:

/s/ Michael McClellan

Name:

Michael McClellan

Title:

Executive Vice President and Chief

Financial Officer